Management of opioid-induced bowel dysfunction.

Area of Science:

• Oncology
• Gastroenterology
• Palliative Care

Background:

• Opioid-induced bowel dysfunction (OIBD) is a significant challenge in cancer care.
• Effective management of OIBD is essential for patient comfort and treatment adherence.

Purpose of the Study:

• To outline an aggressive management strategy for opioid-induced bowel dysfunction in oncology patients.
• To emphasize the importance of proactive and preventative measures.

Main Methods:

• Initiate bowel regimen with senna and a stool softener upon starting opioid therapy.
• Rapidly titrate laxatives if initial doses are ineffective.
• Add agents like bisacodyl at the first sign of constipation.
• Consider fecal impaction and its associated symptoms.

Main Results:

• Proactive and aggressive management can prevent severe constipation and fecal impaction.
• Timely intervention with appropriate agents is key to successful OIBD management.
• Recognizing symptoms of fecal impaction is critical to avoid complications.

Conclusions:

• Opioid-induced bowel dysfunction requires an aggressive, preventative approach in oncology.
• Patient education on OIBD management is paramount.
• "Remember the bowels" is a critical principle in palliative and oncology care.